[3] Wegovy is administered as a once-weekly subcutaneous injection, with dosing gradually escalated over a standard 16-week titration period (which may be extended if not tolerated)
Monitor renal function when prescribing ORLISTAT to patients at increased risk for oxalate nephropathy, including patients with renal impairment and in those with a history of hyperoxaluria or calcium oxalate nephrolithiasis
Nat Rev Gastroenterol Hepatol
It is unclear whether this observation was due to the effects of time-restricted feeding (ie, intermittent fasting), a lower overall caloric intake with once-daily feeding (ie, caloric restriction), or whether pre-existing health conditions in the dogs may have affected how frequently they were fed
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma
It takes time. Tirzepatide, the newer entrant, is not being shown to be worse for the heart than semaglutide